multiple sclerosis

Started at a brainstorm in Barcelona prior to ECTRIMS 2025, iAIMS works towards AI literacy during their educational session at MSToronto 2026

Due to the health situation all over Europe, EAN had to cancel the in-person Spring School 2020, but thanks to a very enthusiastic faculty, we were able to hold this course almost with the entire programme as a virtual school.

Prof. Centonze presented the first lecture on the subject of the pathophysiological basis of functional recovery in multiple sclerosis, starting with a discussion on the key role played by synaptic plasticity in recovery of function. He presented convincing data obtained by means of transcranial magnetic stimulation indicating that synaptic plasticity reserve prevents clinical disability in patients with multiple sclerosis, and that rehabilitation favours synaptic remodeling and plasticity. In the second part of his lecture, Prof Centonze demonstrated the relevant role of the activation of NMDA, cannabinoid, and dopamine receptors, and of neurotrophins in modulating synaptic plasticity to clinically compensate tissue damage in multiple sclerosis. As a result, treatments aimed at activating these receptors such as D-aspartate, phytocannabinoids, or L-dopa, may have the potential to enhance the beneficial effects of rehabilitation by favouring synaptic plasticity.

Dear Dr Santuccione-Chadha thank you for very much accepting this interview for EANpages. The EAN, as leading European society in the field of neurology, is very interested in the WBP. Could you summarize the project to the readers of EANpages? The Women’s Brain Project (WBP) is an interdisciplinary, global non-profit organization founded in 2016 in Switzerland. Composed of academic and social scientists, medical doctors, engineers, patients, caregivers, artists and AI experts, WBP works to identify specific needs related to women’s brain and mental health, advocate for change, and position the findings for the benefit of society.

For March 2019, we have selected: Burt RK Balabanov, MD Burman J, et al. Effect of nonmyeloablative haematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis. JAMA 2019;321(2):165-174. Stem cells are a highly topical research area in clinical neurology. Approaches vary from attempts at nerve regeneration to exploitation of immunological effects.

8th Winter Course on Movement Disorders 54th Turkish National Neurology Congress

The November issue of the European Journal of Neurology is online!

by Prof. Radu Tanasescu   Paper: Maggi et al. ‘Central Vein Sign Differentiates Multiple Sclerosis from Central Nervous System Inflammatory Vasculopathies’. Annals of Neurology. 2018;83:283–294. Outline: This paper shows for the first time that central vein assessment in white matter… Continue Reading

The new CME article March 2018: “EAN and ESO consensus statement and practical guidance for pre-hospital management of stroke” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning… Continue Reading

It is a great pleasure to introduce the recipients of the Research Fellowship 2018 (in alphabetical order):

Report from Dr Anca Adriana Arbune, from Bucharest, Romania visiting the Neurophysiology Department, Filadelfia Hospital, Dianalund, Denmark under the supervision of Prof. Sándor Beniczki.

  The Panel met at the EAN Congress in Amsterdam and the Co-Chairs presented the main points from the Panel Chairs meeting.  It was agreed that the Panel would approach all members to suggest a Neurologist in training to join… Continue Reading